CoChat

Cerebrospinal fluid biogenic amine metabolites, plasma‐rich platelet serotonin and [3H]imipramine reuptake in the primary fibromyalgia syndrome

Legangneux, E., Mora, J. J., Spreux‐Varoquaux, O., Thorin, I., Herrou, M., Alvado, G., Gomeni, C. · 2001 · Rheumatology
Cited by 120

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Primary fibromyalgia syndrome (PFS) is a chronic disorder commonly seen in rheumatological practice. The pathophysiological disturbances of this syndrome, which was defined by the American College of Rheumatology in 1990, are poorly understood. This study evaluated, in 30 patients, the hypothesis that PFS is a pain modulation disorder induced by deregulation of serotonin metabolism. OBJECTIVES: To compare platelet [(3)H]imipramine binding sites and serotonin (5-HT) levels in plasma-rich platelets (PRP) of PFS patients with those of matched healthy controls and to compare the levels of biogenic amine metabolites in the cerebrospinal fluid (CSF) of PFS patients with those of matched controls. METHODS: Platelet [(3)H]imipramine binding sites were defined by two criteria, B(max) for their density and K(d) for their affinity. PRP 5-HT and CSF metabolites of 5-HT (5-hydroxyindoleacetic acid, 5-HIAA), norepinephrine (3-methoxy, 4-hydroxy phenylglycol, MHPG) and dopamine (homovanillic acid, HVA) were assayed by reversed-phase high-performance liquid chromatography with coulometric detection. RESULTS: [(3)H]Imipramine platelet binding was similar (P=0.43 for B(max) and P=0.30 for K(d)) in PFS patients (B(max)=901+/-83 fmol/mg protein, K(d)=0.682+/-0.046) and in matched controls (B(max)=1017+/-119 fmol/mg protein, K(d)=0.606+/-0.056). PRP 5-HT was significantly higher (P=0.0009) in PFS patients (955+/-101 ng/10(9) platelets) than in controls (633+/-50 ng/10(9) platelets). When adjusted for age, the levels of all CSF metabolites were lower in PFS patients. The CSF metabolite of norepinephrine (MHPG) was lower (P:=0.003) in PFS patients (8.33+/-0.33 ng/ml) than in matched controls (9.89+/-0.31 ng/ml) and 5-HIAA was lower (P=0.042) in PFS female patients (22.34+/-1.78 ng/ml) than in matched controls (25.75+/-1.75 ng/ml). For HVA in females, the difference between PFS patients (36.32+/-3.20 ng/ml) and matched controls (38.32+/-2.90 ng/ml) approached statistical significance (P=0.054). CONCLUSION: Changes in metabolites of CSF biogenic amines appear to be partially correlated to age but remained diagnosis-dependent. High levels of PRP 5-HT in PFS patients were associated with low CSF 5-HIAA levels in female patients but were not accompanied by any change in serotonergic uptake as assessed by platelet [(3)H]imipramine binding sites. These findings do not allow us to confirm that serotonin metabolism is deregulated in PFS patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/rheumatology/40.3.290

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 28

  1. Smythe HA. ‘Fibrositis’ as a disorder of pain modulation. Clin Rheum Dis1979;5:823–32. · DOI
  2. Wolfe F, Hawley D, Cathey MA. Fibrositis: symptoms, frequency and criteria for diagnosis. J Rheumatol1985; 12:1159–63.
  3. Wolfe F, Smythe HA, Yunus MB et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum1990;33:160–72. · DOI · Paper page
  4. Bartels EM, Danneskiold‐Samsoe B. Histological abnormalities in muscle from patients with certain types of fibrositis. Lancet1984;1:755–7. · DOI
  5. Bengtsson A, Henriksson KG, Larsson J. Muscle biopsy in primary fibromyalgia: light microscopal and histochemical findings. Scand J Rheumatol1986;15:1–6. · DOI · Paper page
  6. Moldofsky H, Warsh JJ. Plasma tryptophan and musculoskeletal pain in non‐articular rheumatism (‘fibrositis syndrome’). Pain1978;5:65–71. · DOI · Paper page
  7. Moldofsky H. Rheumatic pain modulation syndrome: the interrelationships between sleep, central nervous system serotonin and pain. Adv Neurol1982;33:51–7.
  8. Murphy RM, Zemla FP. Differential effects of substance P on serotonin‐modulated spinal nociceptive reflexes. Psychopharmacology1987;93:118–21. · DOI
  9. Russel IJ, Vaeroy H, Javors M, Nyberg F. Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum1992; 35:550–6. · DOI · Paper page
  10. Russel IJ, Michalek JE, Vipraio GA, Flechter EM, Javors MA, Bowden CA. Platelet 3H‐imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome. J Rheumatol1992; 19:104–9.
  11. Mellerup E, Langer SZ. A World Health Organization collaborative study: Validity of imipramine platelet binding sites as a biological marker of endogenous depression. Pharmacopsychiatry1990;23:113–7. · doi:10.1055/s-2007-1014492
  12. Spreux‐Varoquaux O, Gailledreau J, Vanier B et al. Initial increase of plasma free serotonin: a biological predictor for the antidepressant response to clomipramine. Biol Psychiatry1996;40:465–73. · doi:10.1016/0006-3223(95)00449-1
  13. Matson WR, Langlais P, Volicer L, Gamache PH, Bird E, Mark KA. n‐Electrode three dimensional liquid chromatography with electrochemical detection for determination of neurotransmitter. Clin Chem1984;30:1477–88. · doi:10.1093/clinchem/30.9.1477
  14. Poirier MF, Benkelaft C, Loo H et al. Reduced Bmax of 3H‐imipramine binding to platelets of depressed patients free of previous medication with 5HT uptake inhibitors. Psychopharmacology1986;89:456–61. · DOI
  15. Briley MS, Langer SZ, Raisman R, Sechter D, Zarifian E. Tritiated imipramine binding sites are decreased in platelets of untreated depressed patients. Science1980;209:303–5. · DOI · Paper page
  16. Carsten ME, Engelbrecht AH, Russel VA et al. Imipramine binding sites on platelets of patients with major depressive disorder. Psychiatry Res1986;18:333–42. · DOI
  17. Owens MJ, Nemeroff CB. Role of the serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin Chem1994;40:288–95. · DOI · Paper page
  18. Hudson JI, Hudson MB, Pliner LF, Goldenberg DL, Pope HG. Fibromyalgia and major affective disorder: a controlled phenomenology and family history study. Am J Psychiatry1985;142:441–6. · DOI · Paper page
  19. Goldenberg DL. Psychiatric and psychological aspects of fibromyalgia syndrome. Rheum Dis Clin North Am1989;15:105–15. · DOI
  20. Ahles TA, Yunus MB, Masi AT. Is chronic pain a variant of depressive disease? The case of primary fibromyalgia syndrome. Pain1987;29:105–11. · DOI · Paper page
  21. Kravitz MH, Katz R, Kot E, Helmke N, Fawcett J. Biochemical clues to a fibromyalgia–depression link: imipramine binding in patients with fibromyalgia or depression and in healthy controls. J Rheumatol1992; 19:1428–32.
  22. Magni G, Andreoli F, Arduino C. 3H‐Imipramine binding sites are decreased in platelets of chronic pain patients. Acta Psychiatr Scand1987;75:108–10. · doi:10.1111/j.1600-0447.1987.tb02760.x
  23. Wolfe I, Russel IJ, Vipraio G, Ross K, Anderson J. Serotonin levels, pain threshold and fibromyalgia symptoms in the general population. J Rheumatol1997; 24:555–9.
  24. Schwarz MJ, Spath M, Muller‐Bardorff H, Pongratz DE, Bondy B, Ackenheil M. Relationship of substance P, 5‐hydroxyindole acetic acid and tryptophan in serum of fibromyalgia patients. Neurosci Lett1999;259:196–8. · DOI
  25. Stratz T, Samborski W, Hrycaj P et al. Serum serotonin concentration in patients with generalized tendomyopathy (fibromyalgia) and rheumatoid arthritis. Med Klin1993; 88:458–62.
  26. Blennow K, Wallin A, Gottfries CG et al. Cerebrospinal fluid monoamine metabolites in 114 healthy individuals 18–88 years of age. Eur Neuropsychopharmacol1993; 3:55–61. · DOI
  27. Bowers M, Gerbode F. The relationship of monoamine metabolite in human CSF to age. Nature1968; 219:1256–7. · DOI
  28. Gottfries CG, Gottfries I, Johansson B et al. Acid monoamine metabolites in human CSF and their relationship to age and gender. Neuropharmacology1971;10:665–72. · doi:10.1016/0028-3908(71)90081-5

Cited by

See all 120

Metadata

Authors
Legangneux, E., Mora, J. J., Spreux‐Varoquaux, O., Thorin, I., Herrou, M., Alvado, G., & Gomeni, C.
Venue
Rheumatology
Published
2001-03
Volume
40
Issue
3
Pages
290-296
ISSN
  • 1462-0324 (ISSN-L)
  • 1462-0332
OpenAlex
W2085189002
Cited by
120
References
3
FWCI
2.03
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cerebrospinal fluid biogenic amine metabolites, plasma‐rich platelet serotonin and [3H]imipramine reuptake in the primary fibromyalgia syndrome. https://app.cochat.ai/papers/10.1093/rheumatology/40.3.290
The paper
Legangneux, E., Mora, J. J., Spreux‐Varoquaux, O., Thorin, I., Herrou, M., Alvado, G., & Gomeni, C. (2001). Cerebrospinal fluid biogenic amine metabolites, plasma‐rich platelet serotonin and [3H]imipramine reuptake in the primary fibromyalgia syndrome. Rheumatology. https://doi.org/10.1093/rheumatology/40.3.290

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.